Concepedia

Author

Stephan Probst

Jewish General HospitalORCID

Also Known As

Marckmann, Georg, Probst, S, S Probst, S. Probst, SM Probst, Stephan M. Probst, Stephan Michael Probst, Stephan Probst

159

Publications

7.2K

Citations

27

H-Index

78

Concepts

All Affiliations

Jewish General HospitalKrankenhaus NordwestHeidelberg UniversityMcGill UniversityUniversity Hospital Heidelberg
SP

About

Stephan Probst is an author at Jewish General Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

28

4.5K

2

Health Sciences

7

7

140

3

Public Health

3

3

132

4

Cardiothoracic Surgery

2

2

25

5

Engineering

1

1

19

Stephan Probst

×

46

Publications

6.7K

Citations

26

H-Index

YearCitations

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk,

The Lancet

2019

2.4K

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

Salah‐Eddin Al‐Batran, J. T. Hartmann, Stephan Probst,

Journal of Clinical Oncology

2008

778

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Claudia Pauligk,

The Lancet Oncology

2016

713

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk,

JAMA Oncology

2017

458

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe,

The Journal of Urology

2021

352

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

S. Al-Batran, J. T. Hartmann, Ralf‐Dieter Hofheinz,

Annals of Oncology

2008

278

Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.

Salah‐Eddin Al‐Batran, Nils Homann, Harald Schmalenberg,

Journal of Clinical Oncology

2017

238

Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer

Jeffrey How, Walter H. Gotlieb, Joshua Z. Press,

Gynecologic Oncology

2015

161

Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementia

Carlos Roncero, Heike Kniefel, Erik Service,

Alzheimer s & Dementia Translational Research & Clinical Interventions

2017

114

Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis

Ahmad Chaddad, Tamim Niazi, Stephan Probst,

Frontiers in Oncology

2018

90

Page 1